ACRO Biocornea Clinical Trial in Taiwan

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

October 5, 2022

Study Completion Date

March 6, 2023

Conditions
Corneal Ulcer
Interventions
DEVICE

Lamellar keratoplasty-ABCcolla® Collagen Ophthalmic Matrix

Lamellar keratoplasty was done by removing stromal layer, ABCcolla® Collagen Ophthalmic Matrix was sutured to the defective part of the cornea.

Trial Locations (3)

Unknown

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Kaohsiung Veterans General Hospital, Kaohsiung City

Tri-Service General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

ACRO Biomedical Co. Ltd

INDUSTRY